In this episode of Macro Bites, EY-Parthenon Chief Economist Gregory Daco and EY-Parthenon Americas Life Sciences Sector Leader Ranu Carroll discuss a new economic paradigm, supply chain dynamics, imports of active pharmaceutical ingredients and what we’re hearing from clients.

Watch the episode

Key takeaways

  1. Building resilient supply chains through onshoring and diversification is essential in today’s uncertain, tariff-pressured global environment.
  2. Innovation, particularly embracing AI, is necessary to drive productivity, reduce costs and remain competitive in the life sciences sector.
  3. Forming alliances or partnerships can be a strategic, low-risk way to navigate market volatility without committing to full acquisitions.

Host and featured guest

gregory daco

Gregory Daco
 EY-Parthenon Chief Economist, Strategy and Transactions

image of ranu carroll

Ranu Carroll
EY-Parthenon Americas Life Sciences Sector Leader

How EY-Parthenon can help

Watch more episodes of Macro Bites

Explore our Macro Bites series for real-time economic insights from industry leaders at EY.

Explore episodes
  •  

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

EY-Parthenon is a brand under which a number of EY member firms across the globe provide strategy consulting services.